BRD4 and leukemia: Moreover, Brd4/BET inhibition triggered terminal differentiation of AML blasts (Fig. 7d), inducing expression of myeloid differentiation marker while decreasing that of leukemia stem cell marker (Supplementary Fig. 8b).